Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: Alex Greenland who wrote (318)	1/8/1998 6:40:00 PM
From: John McCarthy	Read Replies (1) \| Respond to of 569

Alex - Thanks for posting. I read this thing 10 times at work. It is VERY CONFUSING. BUT IT IS A GOOD confusion. Here is what I mean: With respect to 1997: --------------------- We are at """Reported Earnings - YTD""" of $1.21. They say, ... "although reported earnings could exceed $1.40" Okay - we can do this -> $1.40 - $1.21 = .19 of """Reported Earnings""" for the 4th quarter. Trust me, we "know" what fixed costs are for the 4th, we "know" what the GM% is, we "know" what the fee payments are - the only variable left is Product Sales. My 2 cents:to hit $0.19 you have to do $7,300 in Product Sales. That, sir, is a big number! And please note, "our" P&L hits their $0.11 exactly if I change the $1,000 license fee to -0- and use $7,300 in Product Sales. I realize the rest of the post is a blast too, but I just chickened out a week ago and forecast 4th quarter product sales of $5,600. Duh! Regards and Enjoy! John